A systematic review and meta-analysis of seven randomized controlled trials (314 participants) found that combining bisphosphonates with structured physical interventions produced a statistically significant improvement in femoral neck bone mineral density (MD = 5.27; 95% CI: 2.23–8.32) and quality of life scores (MD = 30.16; 95% CI: 22.16–38.16) compared with bisphosphonates alone. Gains at the lumbar spine, total hip, and total body BMD did not reach statistical significance. Critically, heterogeneity was extreme across most outcomes (I² = 88–100%), signalling that pooled estimates should be interpreted with caution.
Osteoporosis affects an estimated 200 million people globally, and bisphosphonates remain the pharmacological backbone of treatment. The mechanistic logic here is sound: mechanical loading stimulates osteoblast activity through Wnt/β-catenin and mechanosensory pathways that bisphosphonates do not directly activate, suggesting genuine complementarity rather than redundancy. The site-specific femoral benefit aligns with prior evidence that weight-bearing and resistance exercise preferentially loads the hip — precisely where fractures carry the highest mortality risk.
However, this meta-analysis has serious limitations. Just seven trials with 314 total participants is a thin evidence base. The extreme heterogeneity (I² up to 100%) means the pooled numbers may obscure as much as they reveal, reflecting widely varying exercise types, intensities, durations, and patient profiles. The finding is best read as hypothesis-confirming rather than practice-changing — a prompt for clinicians to routinely pair bisphosphonate prescriptions with targeted hip-loading exercise programmes, while awaiting larger, protocol-standardised trials.